Two successfully completed pregnancies in adult onset Pompe disease, under continued treatment with alglucosidase alfa

被引：0
|
作者：
Julie Van Houtte
Jan L. De Bleecker
机构：
[1] Ghent University Hospital,Department of Neurology and Neuromuscular Reference Centre
来源：
Acta Neurologica Belgica | 2019年 / 119卷
关键词：
Pompe disease; Enzyme replacement therapy; Pregnancy; Myopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of cipaglucosidase alfa/miglustat versus alglucosidase alfa/placebo in late-onset Pompe disease: PROPEL study
    Kishnani, Priya
    Bratkovic, Drago
    Byrne, Barry
    Diaz-Manera, Jordi
    Laforet, Pascal
    Mozaffar, Tahseen
    van der Ploeg, Ans
    Roberts, Mark
    Toscano, Antonio
    Jiang, Hai
    Sitaraman, Sheela
    Goldman, Mitchell
    Castelli, Jeff
    Schoser, Benedikt
    [J]. GENETICS IN MEDICINE, 2022, 24 (03) : S96 - S96
  • [22] Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
    Priya S Kishnani
    Deya Corzo
    Nancy D Leslie
    Daniel Gruskin
    Ans van der Ploeg
    John P Clancy
    Rosella Parini
    Gilles Morin
    Michael Beck
    Mislen S Bauer
    Mikael Jokic
    Chen-En Tsai
    Brian W H Tsai
    Claire Morgan
    Tara O'Meara
    Susan Richards
    Elisa C Tsao
    Hanna Mandel
    [J]. Pediatric Research, 2009, 66 : 329 - 335
  • [23] INFUSION-ASSOCIATED REACTIONS AND NEUTRALIZING ANTIBODY FORMATION IN AN ADULT WITH POMPE DISEASE RECEIVING ALGLUCOSIDASE ALFA
    de Vries, J.
    Kroos, M.
    Ozkan, L.
    van der Ploeg, A. T.
    Reuser, A. J. J.
    [J]. CLINICAL THERAPEUTICS, 2010, 32 : S72 - S72
  • [24] Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
    Kishnani, Priya S.
    Corzo, Deya
    Leslie, Nancy D.
    Gruskin, Daniel
    van der Ploeg, Ans
    Clancy, John P.
    Parini, Rosella
    Morin, Gilles
    Beck, Michael
    Bauer, Mislen S.
    Jokic, Mikael
    Tsai, Chen-En
    Tsa, Brian W. H.
    Morgan, Claire
    O'Meara, Tara
    Richards, Susan
    Tsao, Elisa C.
    Mandel, Hanna
    [J]. PEDIATRIC RESEARCH, 2009, 66 (03) : 329 - 335
  • [25] Case report of patient with infantile-onset Pompe disease treated with alglucosidase alfa beginning at age 16
    Phalin, Judith
    Powell, Berkley R.
    Winter, Susan C.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S26 - S27
  • [26] Results of Prolonged Follow-Up of Late-Onset Pompe Disease Treated with Alglucosidase Alfa (Myozyme®)
    Laforet, P.
    Payan, C.
    Laloui, K.
    Hogrel, J-Y.
    Wary, C.
    Carlier, R.
    Pellegrini, N.
    Bedat-Millet, A-L.
    Durieu, I.
    Furby, A.
    Penisson-Besnier, I.
    Praline, J.
    Orlikowski, D.
    Guffon-Fouilhoux, N.
    Levy, A.
    Eymard, B.
    [J]. CLINICAL THERAPEUTICS, 2011, 33 : S34 - S34
  • [27] Myozyme treatment for adult onset Pompe disease
    Flynn, P.
    Howard, L.
    Deegan, P.
    Cox, T.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 888 - 888
  • [28] A review of the clinical progression in six late onset Pompe disease (LOPD) patients following alglucosidase alfa cessation
    Oldham, Andrew J.
    Stepien, Karolina M.
    Roberts, Mark E.
    Sharma, Reena
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 95 - 96
  • [29] Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
    Dornelles, A. D.
    Junges, A. P. P.
    Krug, B.
    Goncalves, C.
    de Oliveira Junior, H. A.
    Schwartz, I. V. D.
    [J]. FRONTIERS IN PEDIATRICS, 2024, 12
  • [30] Results of prolonged follow-up of late-onset Pompe disease treated with alglucosidase alfa (Myozyme)
    Eymard, B.
    Payan, C.
    Laloui, L.
    Hogrel, J. Y.
    Wary, C.
    Carlier, R.
    Pellegrini, N.
    Bedat-Millet, A. L.
    Durieu, I.
    Furby, A.
    Penisson-Besnier, I.
    Praline, J.
    Orlikowski, D.
    Guffon-Fouilhoux, N.
    Levy, A.
    Laforet, P.
    [J]. NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 673 - 674
12345